Gene-Targeted heart drug aims to prevent second attacks
Disease control
Recruiting now
This study tests a drug called dalcetrapib in 2,000 people who have a specific gene (AA genotype) and recently had a heart attack or related event. The goal is to see if the drug can lower the chance of another heart attack or stroke. Participants will take either the drug or a p…
Phase: PHASE3 • Sponsor: DalCor Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:59 UTC